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SUMMARY
Objective: To describe clinical/laboratory features of patients undergoing coronary ar-
tery bypass graft (CABG) in a cardiology reference center. Methods: Cohort study; data 
from patients undergoing CABG (January 2004 to February 2006, n = 717) were evalu-
ated for clinical/laboratory features before, during and after surgery (infections, duration 
of hospital stay, deaths). Results: Patients were 61.9 ± 11 years old, 67.1% males, 29.6% 
diabetics. Intraoperatively, diabetics had a central venous catheter placed for a longer pe-
riod (p < 0.001), but extracorporeal circulation, aortic clamping and total surgery times 
were similar to those for non-diabetics. Infection occurred in 19.1% of patients (40.1% 
diabetics vs. 10.3% non-diabetics, p < 0.001). The duration of hospital stay was longer for 
patients with diabetes vs. non-diabetic patients, but there was no difference in deaths be-
tween the two groups (p = 0.797). Conclusion: Patients with diabetes undergoing CABG 
develop more infectious diseases and stay longer in hospital than non-diabetics.
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INTRODUCTION
Diabetes mellitus (DM) is an independent risk factor for 
coronary artery disease, stroke and heart failure, the main 
death causes in these patients1. Coronary artery disease 
has a higher incidence and is more severe in patients 
with DM compared to non-diabetic patients, affecting 
females2 predominantly and causing multiple artery dam-
age, forming unstable/more prone to rupture atheromata, 
leading to a worse prognosis for these patients: a lower 
short-term survival, a higher disease recurrence risk and 
a worse response to proposed treatments3,4. Among treat-
ments, coronary artery bypass graft (CABG) has improved 
the survival in patients with severe coronary artery dis-
ease, surpassing medication treatment in those cases, es-
pecially in patients with DM4.
However, several studies have shown a higher postop-
erative complication rate in these patients after heart sur-
geries, with reoperation and reintubation requirement, su-
perficial and deep infections, perioperative stroke, kidney 
failure and longer hospital stay being highlighted5,6. How-
ever, previous studies by other authors6 in our country did 
not show an association between DM and perioperative 
mortality risk7. As early as preoperatively, patients with 
DM are already different from those without DM, with 
older age8, lower ejection fraction5, higher obesity fre-
quency, systemic arterial hypertension and cardiovascular 
disease history being more commonly found8.
The identification of the clinical and laboratory profile 
of patients with DM before CABG and its relationship with 
clinical outcomes is a key factor for a better care planning, 
with subsequent improvement of outcomes and reduced 
hospital cost. Therefore, this study objective was to evalu-
ate the risk profile of patients with DM undergoing CABG 
in a reference service in Southern Brazil, by comparing the 
clinical end-point frequency with that in patients without 
DM, identifying the main outcome predictor factors in 
this group.
METHODS
A cohort study was conducted, with data being collected 
from all patients undergoing CABG from January 2004 
through February 2006 in a reference service in the state 
of Rio Grande do Sul, Brazil. The exclusion criteria were: 
urgent surgery, no admission plasma glucose recorded, ev-
idence of any infection within 36 hours from the surgery, 
and evidence of any postoperative infection (positive cul-
tures or antibiotic use). 717 patients were included, from 
whom 212 (29.6%) had DM (defined by a DM history, use 
of oral antidiabetics or a fasting blood glucose 126 mg/dL 
at the admission).
The data were retrospectively collected, by complet-
ing a form containing demographic and identification 
(name, gender, race, age), clinical (weight, height, blood 
pressure, heart rate, axillary temperature, medication 
used, capillary glucose over the first 48 h postoperative-
ly), laboratory (fasting plasma glucose, hematocrit, white 
blood cell count, platelets, creatinine, sodium, potassium), 
intraoperative (operative time and time with extracorpo-
real circulation, aortic clamping, mechanical ventilation, 
central venous catheter and urinary catheters) variables 
and comorbidities (hypertension, diabetes mellitus, smok-
ing, obesity, dyslipidemia, prior acute myocardial infarct, 
heart failure, chronic kidney failure, prior stroke, prior 
neoplasm). The glomerular filtration rate was calculated 
through the Cockcroft-Gault equation9.
The evaluated end-points, depending on whether DM 
is present or not, were: infections, postoperative hospital 
stay and deaths. The patient was considered to have post-
operative infection in the following situations: respiratory 
tract infection (defined as the presence of a positive spu-
tum test or a recent chest XR infiltrate not characterized 
clinically as resulting from heart failure), urinary tract 
infection (defined as the presence of a positive urine cul-
ture or a high white blood cell count in urine), superficial 
wound operatory infection (clinical diagnosis registered 
in the patient record, being only the skin and the subcu-
taneous tissue affected) or deep wound operatory infec-
tion (clinical diagnosis registered in the patient record as 
affecting mediastinum, bone or cartilage tissue with ne-
crotic tissue present or not). In individuals experiencing 
more than one infectious episode, only the first one was 
considered to have the incidence calculated.
This study was approved by the Institutional Ethics 
Committee. The authors provided an agreement in which 
they pledged themselves to use the information with an 
exclusively scientific purpose, fully preserving the patient 
anonymity.
The statistical analysis was conducted by using the 
software Statistical Package for Social Sciences (SPSS ver-
sion 17.0). The sample characteristics were described by 
mean, standard deviation, median, interquartile ranges, 
ratios and occasional differences between patients with 
and without DM via Chi-square and Student’s t test. The 
significance level considered was of 0.05.
RESULTS
The preoperative demographic, clinical, laboratory and co-
morbidity characteristics of the 717 patients in the study, 
depending on whether DM is present or not, are shown 
in Table 1. The age was similar for both groups; however, 
among the patients with DM, a lower ratio of males (60.8% 
vs. 70.1%), a higher number of patients reporting dyslip-
idemia (46.2% vs. 14.1%) and a higher number of hyper-
tension cases (89.2% vs. 56.6%) were observed. These pa-
tients also had higher preoperative fasting plasma glucose 
as expected (114.2 ± 36.3 mg/dL vs. 102.8 ± 27.1 mg/dL, 
p < 0.001), a lower glomerular filtration rate (p < 0.001) 
and a higher total count of blood white cells (p < 0.001).
PRISCILA LEDUR ET AL.
196 Rev Assoc Med Bras 2011; 57(2):194-198
As for intraoperative characteristics, the extracorpo-
real circulation, aortic clamping and total surgery times 
were similar between individual with and without DM. 
Postoperatively, the patients with DM had a central ve-
nous catheter placed for a longer time (p < 0.001). The 
mean capillary glucose was higher postoperatively 
(123.7 ± 31.3 mg/dL) than the preoperative plasma glu-
cose (114.2 ± 36.3 mg/dL, p = 0.007), considering only 
patients with DM. The intraoperative characteristics 
and postoperative comorbidities for the 717 patients in 
the study, depending on the presence or not of DM, are 
shown in Table 2.
One hundred and thirty-seven patients (19.1%) had 
some kind of infection, of which 85 were respiratory tract 
infections (62%), 13 were urinary tract infections (9.5%), 35 
were superficial wound operatory infections (25%), and 5 
were deep wound operatory infections (3.6%). Considering 
the patients that had any infection, 85 (40.1%) had DM and 
52 (10.3%) did not have DM, p < 0.001. Figure 1 shows the 
categories and respective infection prevalence, comparing 
patients with and without DM. The most common infection 
in patients with DM was superficial skin infection (16.5%). 
In individuals without DM, only one patient showed respi-
ratory tract infection (10.3%). There was no difference be-
tween the prevalence of respiratory tract infection between 
patients with and without DM (p = 0.062).
Considering only patients with DM, there was no dif-
ference between the mean capillary glucose evaluated 
within 48 h after the surgery and the presence of infection 
in these patients (126.3 ± 31.6 vs. 121.9 ± 31.0 mg/dL in 
patients with DM and infection vs. patients with DM with-
out infection, p = 0.702).
Characteristics
With diabetes
n = 212
Without diabetes
n = 505
p value
Age (years) 61.0 ± 10.7 62.3 ± 10.8 0.913
Elderly (> 65 years) 132 (62.3) 281 (55.6) 0.120
Males 129 (60.8) 354 (70.1) 0.020
Race 0.222
White 168 (90.8) 417 (93.8)
Non-white 17 (9.2) 27 (6.1)
Prior neoplasm 1 (0.5) 2 (0.4) 1.000
Coronary angiography during hospitalization 156 (73.6) 372 (73.8) 1.000
Percutaneous coronary intervention during hospitalization 13 (6.1) 29 (5.7) 0.977
Prior AMI 37 (17.5) 89 (17.6) 1.000
Prior stroke 22 (10.4) 48 (9.5) 0.825
COPD 24 (11.3) 58 (11.5) 1.000
Dyslipidemia 98 (46.2) 71 (14.1) < 0.001
BMI (kg/m²) 0.715
< 25 95 (47.5) 223 (44.2)
25-30 72 (36.0) 191 (37.8)
> 30 33 (16.5) 91 (18.0)
Hypertension 189 (89.2) 286 (56.6) < 0.001
Blood pressure (mmHg)
Systolic 132.8 ± 15.6 129.3 ± 16.1 0.006
Diastolic 82.5 ± 10.9 74.5 ± 8.9 < 0.001
Heart rate (bpm) 83.3 ± 10.4 77.5 ± 8.8 < 0.001
Respiratory rate (RR) 18.0 ± 2.6 16.6 ± 2.0 < 0.001
Preoperative fasting plasma glucose (mg/dL) 114.2 ± 36.3 102.8 ± 27.1 < 0.001
GFR (mL/min) 74.8 ± 28.3 89.0 ± 42.4 < 0.001
Preoperative white blood cell count 7658.7 ± 2106.3 6557 ± 1021 < 0.001
Data is expressed by means ± standard deviation (Student’s t Test) or n and percentage in brackets (Chi-square test). AMI, acute myocardial 
infarction; COPD, chronic obstructive pulmonary disease; BMI, body mass index; GFR, glomerular filtration rate, as calculated by the 
Cockcroft-Gault equation.
Table1 –  Preoperative clinical and demographic characteristics in 717 patients undergoing coronary artery bypass graft, 
depending on whether diabetes is present or not
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The stay in hospital was longer in patients with DM 
(8.8 ± 3.9 days) vs. patients without DM (6.4 ± 1.4 days, 
p < 0.001).
No difference in number of deaths was found between 
patients with (10;  4.7%) and without DM (20;  4.0%), 
p = 0.797.
DISCUSSION
The data presented here reports the differences before and 
after coronary artery bypass graft in patients with DM in 
Brazil. The higher occurrence of infections postoperatively 
and the longer time of a central venous catheter placed in 
patients with DM are featured. These facts likely contrib-
uted to the longer stay in hospital, although they were not 
reflected in higher in-hospital mortality for these patients.
A higher percentage of postoperative infections in 
CABG was also observed by other authors4,10-14, with a 
few exceptions15-18. Considering patients with DM, their 
disadvantage over patients without DM for any CABG 
postoperative infection, especially deep wound infection, 
was maintained, as other authors show11. The experience 
other centers have in implementing a hyperglycemia in-
tensive management protocol with a continuous insulin 
infusion13,16 and/or subcutaneous insulin8 in this setting 
may reduce those rates, in addition to lowering mortal-
ity and cost16, thus reinforcing the implementation we 
have already provided in our Institute. It is important to 
remember that patients with a more severe and more com-
plicated atherosclerotic disease, including those with DM, 
are expected to have a surgery indicated more often than 
a percutaneous intervention, what certainly contributes to 
higher postoperative complication odds.
In addition to the higher postoperative infection risk 
in coronary artery bypass graft, patients with diabetes were 
more frequently females and dyslipidemia, obesity and hy-
pertension were more commonly identified among them, 
what is expected, since there is an association between 
these conditons19. Lower glomerular filtration rates and 
higher heart rates in patients with diabetes are likely due 
to the occurrence of a kidney disease6 and an autonomic 
neuropathy20 in this group, respectively. A higher white 
blood cell count before the surgery would be caused by a 
chronic inflammation state previously described in these 
individuals, where the common soil theory contributes 
both to atherosclerosis and diabetes development as a part 
of the same phenomenon associated with a mild chronic 
systemic infection21.
These are suggested mechanisms to explain why DM 
would make CABG prognosis worse: poorer neutrophil 
phagocytic activity in patients with DM22, a greater num-
ber of prior comorbidities8, a higher renal dysfunction 
prevalence, that is a known marker of both postoperative 
poorer prognosis23 and greater odds of vascular damage 
existing previously to the surgery24, what could determine 
a higher risk of postoperative cardiovascular events. More 
preoperative comorbidities and poorer kidney function 
were shown in our study patients with DM.
The finding of longer stay in hospital resulting from 
diabetes presence needs to be highlighted because it brings 
about an increased cost. Once the association between 
diabetes and diabetes/infection with longer hospital stay 
is identified, the health providers should seek to imple-
ment measures to reduce those outcomes8,13,16,25, resulting 
in a likely cost reduction, which has already been shown in 
other institutions16.
It is important to highlight some of this study limita-
tions, such as the data collect retrospective nature. De-
spite the record quality, other end-points of interest could 
not be assessed, including stroke occurrence, transfusion 
need, reintubation and postoperative dialysis, since these 
end-points had no systematic assessment conducted by 
Table 2 – Intra- and postoperative characteristics in 717 patients undergoing coronary artery bypass graft, depending on 
whether diabetes is present or not
Characteristics
With diabetes  
n = 212
Without diabetes 
n = 505
p value
Extracorporeal circulation time (min) 80.5 ± 29.4 78.3 ± 22.8 0.347
Aortic clamping time (min) 51.6 ± 18.9 51.9 ± 20.1 0.875
Total surgery time (hours) 4.4 ± 0.7 4.3 ± 0.7 0.193
Indwelling central venous catheter (hours) 75.3 ± 35.6 58.7 ± 16.2 < 0.001
Data is expressed by means ± standard deviation (Student’s t Test) or n and percentage in brackets (Chi-square test). DM: diabetes mellitus
Figure 1 – Infection type and prevalence in patients with 
and without diabetes undergoing coronary artery bypass 
graft
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the attending physicians. Finally, this study low power to 
assert postoperative mortality has been similar between 
patients with and without DM should be considered, as 
the study was designed to evaluate composite end-points.
CONCLUSION
We concluded patients with DM undergoing CABG have 
more preoperative comorbidities when clinically assessed 
and have intraoperative characteristics similar to those in 
patients without DM. However, they develop more infec-
tions and stay longer in hospital than those without DM; 
but this is not reflected in higher in-hospital mortality.
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